Blows my mind how under the radar this stock is. Nobody's talking about it and no analyst coverage. From the enormous potential of the drug which appears to be efficacious to Chris Burns and how competent he clearly is, to the share register and the pedigree you see there - everything says undervalued and under the radar to me
Ann: Completion of Recruitment of ACCENT Trial, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.030(12.8%) |
Mkt cap ! $79.53M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 18.5¢ | $7.084M | 32.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 917375 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 5401 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| ATX (ASX) Chart |